Status:
ACTIVE_NOT_RECRUITING
Host Immune Dynamics Following Seasonal Malaria Chemoprevention in African Children
Lead Sponsor:
Malaria Consortium
Collaborating Sponsors:
Stanford University
Conditions:
Malaria,Falciparum
Eligibility:
All Genders
3-15 years
Brief Summary
The study aims to identify immune features linked to protection against malaria, examining variations by age and sex, and measuring changes in immune responses over time following seasonal malaria che...
Detailed Description
This will be a prospective cohort study with participant enrolment done in two districts in the Karamoja sub region. The study population will consist of children aged 3 to 59 months - the target age...
Eligibility Criteria
Inclusion
- Children aged 3 to 59 months and 5-15 years in the selected districts
- Provision of Informed consent by parents/caregivers
Exclusion
- Children known to be immunosuppressed due to malnutrition, HIV or other chronic diseases
Key Trial Info
Start Date :
June 12 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 28 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06524336
Start Date
June 12 2024
End Date
October 28 2024
Last Update
July 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moroto Hospital
Moroto, Karamoja, Uganda